Shares of Apple rose as much as 4.6 percent in intraday trading Monday, following an announcement by co-founder Steve Jobs that he would remain as CEO while undergoing hormone therapy treatment.

The disclosure of a hormone imbalance as the reason for his health decline and that he would remain as CEO while recovering from therapy treatments propelled shares of Apple to as high as $94.91 during intraday trading.